Building Your Child's Care Team and Preparing for Visits
At a Glance
Children with CBAS1 (HSD3B7 deficiency) benefit from a specialized, coordinated team that includes pediatric liver, metabolic, nutrition, pharmacy, and support professionals. Bringing complete lab, genetic, urine, growth, imaging, and medication records helps the team plan care safely.
Because CBAS1 (HSD3B7 deficiency) is so rare, managing it requires more than a general pediatrician. Many pediatric liver centers have never even seen a case of this specific condition [1]. To give your child the best outcome, you need a multidisciplinary team at a specialized center that understands the complex intersection of liver health and metabolic chemistry [2][3].
Your Essential Care Team
Think of your child’s care team as a circle of experts, each looking at a different piece of the puzzle. The core members should include:
- Pediatric Hepatologist: A liver specialist who focuses on children. They will lead the clinical management of the disease, monitoring liver enzymes and overall liver health [4].
- Biochemical Geneticist: This specialist understands the metabolic “pathways” of the body. They interpret the complex urine mass spectrometry tests and help adjust medications [5].
- Specialized Pharmacist: They help ensure continuous access to rare medications like Cholbam, monitor for drug interactions, and provide precise administration guidelines.
- Pediatric Dietitian: Because your child struggles to absorb fats and vitamins (A, D, E, and K), a dietitian is critical for creating a nutrition plan that supports healthy growth [6][5].
- Social Worker / Nurse Coordinator: These professionals help navigate insurance, medication supply planning, telehealth options, and coordinate the intense schedule of appointments and lab tests.
Preparing for Your First Consultation
Specialized centers need accurate data to make the best decisions. When you prepare for your first visit, bring physical or digital copies of the following:
- Laboratory Reports: You need the full, dated history of your child’s blood work (bilirubin, GGT, AST/ALT, INR, and vitamin levels) [4].
- Urine Mass Spectrometry Data: The specialist will want to see the specific levels of atypical bile acids found in the urine [7].
- Genetic Testing Reports: Bring the full report that lists the exact HSD3B7 variants [8][9].
- Growth Charts: A complete history of your child’s height and weight measurements from birth [10].
- Pathology Reports & Imaging: If your child has had an ultrasound, CT scan, or liver biopsy, request the formal pathology report and imaging discs. (The specialist can request the physical tissue slides from the pathology department later if they need to review them) [8][11].
The Benefit of Specialized Care
While your local pediatrician is vital for routine health and vaccinations, they likely do not have the specialized experience to manage a bile acid synthesis defect [1]. Specialized centers have access to advanced metabolic labs, participate in clinical trials, and are equipped to handle the “whole child,” ensuring that the liver, kidneys, and bones are all being monitored simultaneously [8][12].
Action Step: Create a Care-Team Card
Ask your specialist to help you create a one-page, printable emergency/medication plan. It should list:
- Diagnosis (HSD3B7 deficiency).
- Current medicines, formulations, and exact doses.
- Allergies.
- Latest PT/INR and bilirubin levels.
- Treating center and primary contact number (including after-hours).
- Written emergency handoff instructions for local pediatricians or emergency departments.
By building a team of experts, you move from reacting to symptoms to proactively managing your child’s long-term health [3].
Common questions in this guide
What specialists should care for a child with CBAS1?
What records should I bring to my child's first CBAS1 visit?
Why is a specialized center important for HSD3B7 deficiency?
What does urine mass spectrometry show in CBAS1?
What should be included in my child's emergency medication plan?
Who can help us manage appointments, insurance, and medication supplies?
How can I organize my child's medical information before specialist visits?
Get notified when new evidence is published on Congenital bile acid synthesis defect type 1.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
Attempt to Determine the Prevalence of Two Inborn Errors of Primary Bile Acid Synthesis: Results of a European Survey.
Jahnel J, Zöhrer E, Fischler B, et al.
Journal of pediatric gastroenterology and nutrition 2017; (64(6)):864-868 doi:10.1097/MPG.0000000000001546.
PMID: 28267072 - 2
Inborn errors of bile acid metabolism in Japan.
Mizuochi T, Takei H, Nittono H, Kimura A
Pediatrics international : official journal of the Japan Pediatric Society 2023; (65(1)):e15490 doi:10.1111/ped.15490.
PMID: 36704863 - 3
Enhancing care coordination for neurofibromatosis type 1 in primary care: insights and applications for rare diseases.
Evans W, Chauhan J, Imam A, Hayward J
Journal of community genetics 2025; (16(6)):747-757 doi:10.1007/s12687-025-00811-5.
PMID: 40608210 - 4
[Infant with 3β-hydroxy-Δ(5)-C27 steroid dehydrogenase deficiency: report of two cases and literatures review].
Li X, Huang Z, Wang H
Zhonghua er ke za zhi = Chinese journal of pediatrics 2015; (53(5)):360-5.
PMID: 26080666 - 5
Bile Acid Synthesis Disorders in Arabs: A 10-year Screening Study.
Al-Hussaini AA, Setchell KDR, AlSaleem B, et al.
Journal of pediatric gastroenterology and nutrition 2017; (65(6)):613-620 doi:10.1097/MPG.0000000000001734.
PMID: 28902093 - 6
Delayed diagnosis of 3β-HSD7 deficiency in adolescence: Two case reports and review of the literature.
Pendleton S, Mostafavi M, Mathew J, et al.
JPGN reports 2026; (7(2)):236-241 doi:10.1002/jpr3.70159.
PMID: 42110141 - 7
Tandem mass spectrometric determination of atypical 3β-hydroxy-Δ5-bile acids in patients with 3β-hydroxy-Δ5-C27-steroid oxidoreductase deficiency: application to diagnosis and monitoring of bile acid therapeutic response.
Zhang W, Jha P, Wolfe B, et al.
Clinical chemistry 2015; (61(7)):955-63 doi:10.1373/clinchem.2015.238238.
PMID: 25931455 - 8
Genetic spectrum and clinical characteristics of 3β-hydroxy-Δ5-C27-steroid oxidoreductase (HSD3B7) deficiency in China.
Zhao J, Setchell KDR, Gong Y, et al.
Orphanet journal of rare diseases 2021; (16(1)):417 doi:10.1186/s13023-021-02041-7.
PMID: 34627351 - 9
The Diagnostic Saga of a Rare Congenital Bile Acid Synthesis Disorder: A Case Report.
Yazbeck N, Hanna-Wakim R, Noun D, Karam PE
Clinical medicine insights. Pediatrics 2025; (19()):11795565251340558 doi:10.1177/11795565251340558.
PMID: 40809789 - 10
Bile Acid Synthesis Disorder Masquerading as Intractable Vitamin D-Deficiency Rickets.
Ahmad O, Nogueira J, Heubi JE, et al.
Journal of the Endocrine Society 2019; (3(2)):397-402 doi:10.1210/js.2018-00314.
PMID: 30746501 - 11
Significance of Genetic Testing in Diagnosing Cholestatic Disease in Infants.
Khan M, Shehzad MU, Khattak UM, et al.
Cureus 2026; (18(2)):e103031 doi:10.7759/cureus.103031.
PMID: 41798580 - 12
Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood.
Gonzales E, Matarazzo L, Franchi-Abella S, et al.
Orphanet journal of rare diseases 2018; (13(1)):190 doi:10.1186/s13023-018-0920-5.
PMID: 30373615
This page is for informational purposes only and does not constitute medical advice. Your child’s pediatric hepatology and metabolic team should tailor testing, medicines, and emergency instructions to your child.